CN Bio, a leader in organ-on-a-chip technology, partnered with Life Science Group (LSG), a UK-based Contract Development and Manufacturing Organisation (CDMO), to develop bespoke media and supplement solutions. With expertise in customised biological processing and manufacturing, LSG provided the flexibility and quality assurance needed to support CN Bio’s innovative systems. The collaboration, which began before the COVID-19 pandemic, has since evolved into a strategic partnership focused on scaling production and addressing unique operational challenges.